logo
Gold Reserve Provides Update on Objections to the Special Master's Final Recommendation in the CITGO Sale Process

Gold Reserve Provides Update on Objections to the Special Master's Final Recommendation in the CITGO Sale Process

Business Wire25-07-2025
PEMBROKE, Bermuda--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) ('Gold Reserve' or the 'Company') announces that, pursuant to the schedule set by the U.S. District Court for the District of Delaware (the 'Court'), various parties filed memoranda in support of objections to the Special Master's Final Recommendation that Gold Reserve's U.S. acquisition subsidiary, Dalinar Energy Corporation, should be selected by the Court to purchase the shares of PDV Holding, Inc. ('PDVH'), the indirect parent company of CITGO Petroleum Corp. ('CITGO').
The objections mostly tracked the 'Notices of Objection' filed on July 7, 2025 (and announced by the Company here) but, in a material change, Red Tree Investments LLC ('Red Tree') stated that 'it no longer objects on the basis that the Court should pick its bid instead of Gold Reserve's.' This means that the Gold Reserve / Dalinar Energy bid recommended by the Special Master is the only conforming bid remaining in the Delaware Sale Process.
The parties that filed memoranda in support of objections are as follows:
Red Tree;
Crystallex International Corporation;
the ConocoPhillips companies (filed a 'limited objection');
the ACL1 companies and OI European Group B.V. (both filed short joinders to certain of the objections filed by Crystallex and the ConocoPhillips companies);
the 'Venezuela Parties' (the Bolivarian Republic of Venezuela, PDVSA, PDVH and CITGO) (filed under seal); and
the 2020 bondholders (joined by the Trustee and Collateral Agent for the 2020 bonds).
Under the Court's schedule, responses to the objections are due by August 7, 2025, and further briefing is then to take place in advance of the August 18, 2025 Sale Hearing. A period of limited discovery regarding the objections is now ongoing.
A copy of the filings can be found here.
A complete description of the Delaware sale proceedings can be found on the Public Access to Court Electronic Records system in Crystallex International Corporation v. Bolivarian Republic of Venezuela, 1:17-mc-00151-LPS (D. Del.) and its related proceedings.
Cautionary Statement Regarding Forward-Looking statements
This release contains 'forward-looking statements' within the meaning of applicable U.S. federal securities laws and 'forward-looking information' within the meaning of applicable Canadian provincial and territorial securities laws and state Gold Reserve's and its management's intentions, hopes, beliefs, expectations or predictions for the future. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. They are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements contained in this press release include, but are not limited to, statements relating to any bid submitted by the Company for the purchase of the PDVH shares (the 'Bid').
We caution that such forward-looking statements involve known and unknown risks, uncertainties and other risks that may cause the actual events, outcomes or results of Gold Reserve to be materially different from our estimated outcomes, results, performance, or achievements expressed or implied by those forward-looking statements, including but not limited to: the discretion of the Special Master to consider the Bid, to enter into any discussions or negotiation with respect thereto; the Bid will not be approved by the Court as the 'Final Recommend Bid' under the Bidding Procedures, and if approved by the Court may not close, including as a result of not obtaining necessary regulatory approvals, including but not limited to any necessary approvals from the U.S. Office of Foreign Asset Control ('OFAC'), the U.S. Committee on Foreign Investment in the United States, the U.S. Federal Trade Commission or the TSX Venture Exchange; failure of the Company or any other party to obtain sufficient equity and/or debt financing or any required shareholders approvals for, or satisfy other conditions to effect, any transaction resulting from the Bid; that the Company may forfeit any cash amount deposit made due to failing to complete the Bid or otherwise; that the making of the Bid or any transaction resulting therefrom may involve unexpected costs, liabilities or delays; that, prior to or as a result of the completion of any transaction contemplated by the Bid, the business of the Company may experience significant disruptions due to transaction related uncertainty, industry conditions, tariff wars or other factors; the ability to enforce the writ of attachment granted to the Company; the timing set for various reports and/or other matters with respect to the Sale Process may not be met; the ability of the Company to otherwise participate in the Sale Process (and related costs associated therewith); the amount, if any, of proceeds associated with the Sale Process; the competing claims of other creditors of Venezuela, PDVSA and the Company, including any interest on such creditors' judgements and any priority afforded thereto; uncertainties with respect to possible settlements between Venezuela and other creditors and the impact of any such settlements on the amount of funds that may be available under the Sale Process; and the proceeds from the Sale Process may not be sufficient to satisfy the amounts outstanding under the Company's September 2014 arbitral award and/or corresponding November 15, 2015 U.S. judgement in full; and the ramifications of bankruptcy with respect to the Sale Process and/or the Company's claims, including as a result of the priority of other claims. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements. For a more detailed discussion of the risk factors affecting the Company's business, see the Company's Management's Discussion & Analysis for the year ended December 31, 2024 and other reports that have been filed on SEDAR+ and are available under the Company's profile at www.sedarplus.ca.
Investors are cautioned not to put undue reliance on forward-looking statements. All subsequent written and oral forward-looking statements attributable to Gold Reserve or persons acting on its behalf are expressly qualified in their entirety by this notice. Gold Reserve disclaims any intent or obligation to update publicly or otherwise revise any forward-looking statements or the foregoing list of assumptions or factors, whether as a result of new information, future events or otherwise, subject to its disclosure obligations under applicable rules promulgated by applicable Canadian provincial and territorial securities laws.
For further information regarding Dalinar Energy, visit: https://www.dalinarenergy.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Court Lets Trump Block Billions of Dollars in Foreign Aid
Court Lets Trump Block Billions of Dollars in Foreign Aid

Yahoo

time7 minutes ago

  • Yahoo

Court Lets Trump Block Billions of Dollars in Foreign Aid

(Bloomberg) -- The Trump administration can cut billions of dollars in foreign assistance funds approved by Congress for this year, a US appeals court ruled. Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' New York Warns of $34 Billion Budget Hole, Biggest Since 2009 Crisis Five Years After Black Lives Matter, Brussels' Colonial Statues Remain For Homeless Cyclists, Bikes Bring an Escape From the Streets In a 2-1 decision on Wednesday, the appellate panel reversed a Washington federal judge who found that US officials were violating the Constitution's separation of powers principles by failing to authorize the money to be paid in line with what the legislative branch directed. The ruling is a significant win for President Donald Trump's efforts to dissolve the US Agency for International Development and broadly withhold funding from programs that have fallen out of favor with his administration, regardless of how Congress exercised its authority over spending. Trump's critics have assailed what they've described as a far-reaching power grab by the executive branch. The nonprofits and business that sued could ask the all of the active judges on the US Court of Appeals for the DC Circuit to reconsider the three-member panel's decision. Judge Karen LeCraft Henderson wrote in the majority opinion that the challengers lacked valid legal grounds to sue over the Trump administration's decision to withhold the funds, also known as impoundment. The US Comptroller General — who leads an accountability arm of Congress — could sue under a specific law related to impoundment decisions, Henderson wrote, but the challengers couldn't bring a 'freestanding' constitutional claim or claim violations of a different law related to agency actions. Henderson, appointed by former President George H.W. Bush, was joined by Judge Greg Katsas, a Trump appointee. The court didn't reach the core question of whether the administration's unilateral decision to refuse to spend money appropriated by Congress is constitutional. Judge Florence Pan, nominated by former President Joe Biden, dissented, writing that her colleagues had turned 'a blind eye to the 'serious implications' of this case for the rule of law and the very structure of our government.' The two consolidated cases before the appeals court only deal with money that Congress approved for the 2024 fiscal year, which ends on Sept. 30. Grantees are poised to lose access to funds if they haven't yet been approved to be spent by federal officials — a precursor to actual payouts — or unless a court order is in place. The administration lost one of its few battles before the US Supreme Court earlier this year in the foreign aid fight. In March, a majority of justices refused to immediately stop US District Judge Amir Ali's injunction taking effect while the legal fight went forward. Since then, however, the challengers have filed complaints with Ali that the administration is failing to obligate or pay out the funds. They've rebuffed the government's position that the delay is part of a legitimate effort to 'evaluate the appropriate next steps' and accused officials of angling to use a novel tactic to go around Congress in order to cut appropriated money. The Trump administration has dramatically scaled back the US government's humanitarian work overseas, slashing spending and personnel and merging the US Agency for International Development into the State Department. The challengers say the foreign aid freeze has created a global crisis, and that the money is critical for malaria prevention, to address child malnutrition and provide postnatal care for newborns. The groups argued that the president and agency leaders couldn't defy Congress' spending mandates and didn't have discretion to decide that only some, let alone none, of the money appropriated by lawmakers should be paid. The president can ask Congress to withdraw appropriations but can't do it on his own, the challengers argued. The Justice Department argued Ali's order was an 'improper judicial intrusion into matters left to the political branches' and that the judge wrongly interfered in the 'particularly sensitive area of foreign relations.' The government also said that the Impoundment Control Act, which restricts the president from overruling Congress' spending decisions, wasn't a law that the nonprofits and business could sue to enforce. The challengers countered that Ali's order blocking the funding freeze was rooted in their constitutional separation-of-powers claim, not the impoundment law. The cases are Global Health Council v. Trump, 25-5097, and AIDS Vaccine Advocacy Coalition v. US Department of State, 25-5098, US Court of Appeals, DC Circuit. (Updated with details from the opinion.) Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan Why It's Actually a Good Time to Buy a House, According to a Zillow Economist Dubai's Housing Boom Is Stoking Fears of Another Crash The Social Media Trend Machine Is Spitting Out Weirder and Weirder Results A $340 Million New York Office Makeover Is Converting Boardrooms to Bedrooms ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance

Business Wire

time38 minutes ago

  • Business Wire

Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. ('Sonendo' or the 'Company'), a leading dental technology company and developer of the GentleWave® System, today reported select financial results for the three-months ended June 30, 2025 and reaffirmed 2025 financial guidance. Select Second Quarter Financial Results Generated $7.4 million of total revenue for the second quarter of 2025, an 11% decline compared to the prior year period, which was expected and driven entirely by lower console sales through a smaller and more cost effective sales team; Reported an increase in gross margin to 41% for the second quarter of 2025, up 320 basis points compared to the prior year period; Reported a $3.6 million reduction in loss from continuing operations compared to the prior period, to $3.9 million for the second quarter of 2025; Drove a 47% year-over-year improvement in Adjusted EBITDA loss to $3.0 million for the second quarter of 2025, driven by focused operational efficiencies; Significantly reduced free cash flow burn to $2.6 million, a 61% reduction compared to the prior year period. 'We are pleased by the continued progress we have made in generating increasing operating leverage in the business, as demonstrated in our second quarter 2025 financial and operational results,' said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. 'In particular, we are selling consoles much more efficiently and with a focus on driving higher procedure instrument utilization. We are also focusing the commercial team's efforts on being more responsive to the clinical needs of our customers and their patients. We recently improved the liquidity profile of the Company in a meaningful way, and we remain steadfastly committed to operational excellence and to position Sonendo for robust, long-term and profitable growth.' As of June 30, 2025, the Company's cash, cash equivalents and short-term investments totaled $9.3 million, and there was $14.2 million of principal outstanding under the Company's credit facility. Financial Guidance The Company is reaffirming the 2025 financial guidance it previously provided, which reflects management's latest expectations and is provided below. (1) See additional information included in the Company's Form 8-K filed with the Securities and Exchange Commission on November 12, 2024 for additional information about the Company's use of these non-GAAP financial measures. Expand About Sonendo Sonendo is a commercial-stage medical technology Company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices. For more information about Sonendo and the GentleWave System, please visit To find a GentleWave doctor in your area, please visit Forward-Looking Statements This news release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the Company's expectations regarding 2025 financial performance, including (among other things) revenue, gross margin, adjusted EBITDA and free cash flow; and the Company's ability to achieve robust, long-term and profitable growth. You are cautioned that such statements are not guarantees of future performance and that our actual results may differ materially from those set forth in the forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions; speak only as of the date they are made; and, as a result, are subject to risks and uncertainties that may change at any time. Factors that could cause the Company's actual results to differ materially from these forward-looking statements are described in detail in the 'Risk Factors' section of the Company's Annual Report on Form 10-K that was filed with the Securities and Exchange Commission on March 26, 2025. Such filings are available at The Company undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as may be required under applicable securities laws. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Gildan acquires HanesBrands in $2.2 billion deal
Gildan acquires HanesBrands in $2.2 billion deal

UPI

time39 minutes ago

  • UPI

Gildan acquires HanesBrands in $2.2 billion deal

Aug. 13 (UPI) -- Canadian clothing manufacturer Gildan announced a deal Wednesday to acquire U.S. clothing company HanesBrand. The $2.2 billion deal was valued at $4.4 billion when including HanesBrands debts as Gildan said it will create a "global basic apparel leader with access to iconic innerwear brands and a low cost manufacturing." "Today is a historic moment in Gildan's journey as we look to join forces with HanesBrands. We are extremely pleased to welcome the HanesBrands' team to the Gildan family," President and CEO of Gildan, Glenn J Chamandy said in a press release. After the transaction closes Gildan intends to review strategic alternatives for Hanesbrands. The shareholders of HanesBrands will receive 0.102 of Gildan and $0.80 in cash for each share of HanesBrands common stock. The agreement is expected to close in late 2025 or early 2026.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store